Cancer sites (ICD-10 code) | All workers (n=93 920) | Worker employed ≥1 years (n=75 785) | Workers started job ≥1996 (n=80 776) | Workers had ≥1 mSv (n=45 862) |
All cancers combined (C00-C96) | ||||
Cases | 3392 | 2962 | 2391 | 2010 |
ERR (95% CI)* | 0.15 (−0.20 to 0.50) | 0.15 (−0.20 to 0.51) | 0.93 (−0.60 to 2.46) | 0.20 (−0.18 to 0.57) |
Solid cancers (C00-C81) | ||||
Cases | 3220 | 2813 | 2268 | 1903 |
ERR (95% CI) | 0.15 (−0.20 to 0.51) | 0.17 (−0.20 to 0.53) | 0.79 (−0.77 to 2.35) | 0.21 (−0.18 to 0.60) |
Solid cancers other than thyroid | ||||
Cases | 2234 | 1992 | 1456 | 1384 |
ERR (95% CI) | 0.24 (−0.15 to 0.64) | 0.26 (−0.15 to 0.66) | 0.92 (−1.05 to 2.90) | 0.35 (−0.10 to 0.79) |
Solid cancers other than thyroid and lung | ||||
Cases | 2075 | 1845 | 1360 | 1281 |
ERR (95% CI) | 0.17 (−0.24 to 0.57) | 0.18 (−0.23 to 0.59) | 0.96 (−1.08 to 3.00) | 0.22 (−0.21 to 0.66) |
All-haematopoietic cancers (C81-C96) | ||||
Cases | 172 | 149 | 123 | 107 |
ERR (95% CI) | 0.09 (−2.02 to 2.20) | −0.12 (−2.02 to 1.99) | 3.80 (−5.24 to 12.9) | 0.03 (−2.09 to 2.15) |
Stomach (C16) | ||||
Cases | 366 | 332 | 229 | 241 |
ERR (95% CI) | −0.38 (−0.80 to 0.04) | −0.38 (−0.77 to 0.01) | −0.40 (−2.36 to 1.56) | −0.38 (−1.05 to 0.30) |
Colorectal (C18-C20) | ||||
Cases | 351 | 317 | 228 | 221 |
ERR (95% CI) | 0.38 (−0.67 to 1.43) | 0.39 (−0.68 to 1.46) | −0.38 (−3.83 to 3.07) | 0.34 (−0.73 to 1.42) |
Liver (C22) | ||||
Cases | 194 | 184 | 112 | 138 |
ERR (95% CI) | 1.39 (−0.55 to 3.33) | 1.37 (−0.57 to 3.31) | −0.35 (−5.13 to 4.43) | 1.34 (−0.67 to 3.35) |
Pancreas (C25) | ||||
Cases | 61 | 51 | 40 | 34 |
ERR (95% CI) | −0.38 (−1.75 to 1.00) | −0.38 (−1.78 to 1.02) | −0.36 (−9.10 to 8.38) | −0.13 (−2.21 to 1.94) |
Lung (C33-C34) | ||||
Cases | 159 | 147 | 96 | 103 |
ERR (95% CI) | 1.15 (−0.71 to 3.02) | 1.21 (−0.71 to 3.12) | 0.45 (−7.14 to 8.05) | 2.25 (−0.60 to 5.09) |
Non-melanoma skin (C44) | ||||
Cases | 38 | 34 | 27 | 28 |
ERR (95% CI) | −0.38 (−2.17 to 1.41) | −0.37 (−2.59 to 1.84) | 21.4 (−15.8 to 58.5) | −0.37 (−2.65 to 1.91) |
Female breast (C50) | ||||
Cases | 326 | 270 | 245 | 171 |
ERR (95% CI) | −0.38 (−0.68 to –0.08) | −0.37 (−1.11 to 0.37) | −1.12 (−4.78 to 2.54) | −0.33 (−1.55 to 0.89) |
Prostate (C61) | ||||
Cases | 156 | 135 | 91 | 94 |
ERR (95% CI) | −0.25 (−1.01 to 0.51) | −0.27 (−1.01 to 0.48) | 5.47 (−8.56 to 19.5) | −0.25 (−1.02 to 0.51) |
Kidney (C64) | ||||
Cases | 122 | 108 | 82 | 74 |
ERR (95% CI) | −0.26 (−1.74 to 1.23) | −0.35 (−1.71 to 1.01) | 2.91 (−6.22 to 12.0) | −0.24 (−1.77 to 1.30) |
Bladder (C67) | ||||
Cases | 62 | 53 | 34 | 45 |
ERR (95% CI) | 0.64 (−1.62 to 2.90) | 0.61 (−1.65 to 2.87) | 11.4 (−16.2 to 39.1) | 0.62 (−1.70 to 2.93) |
Brain and CNS (C70-72) | ||||
Cases | 43 | 39 | 30 | 23 |
ERR (95% CI) | −0.29 (−3.14 to 2.55) | −0.30 (−3.08 to 2.48) | −0.37 (−10.6 to 9.82) | −0.31 (−2.96 to 2.34) |
Thyroid (C73) | ||||
Cases | 986 | 821 | 812 | 519 |
ERR (95% CI) | −0.31 (−1.24 to 0.62) | −0.29 (−1.27 to 0.70) | 0.76 (−1.87 to 3.40) | −0.32 (−1.25 to 0.60) |
NHL (C82-C85, C96) | ||||
Cases | 61 | 55 | 42 | 41 |
ERR (95% CI) | −0.41 (−2.88 to 2.07) | −0.55 (−2.08 to 0.99) | 7.16 (−11.7 to 26.0) | −0.55 (−2.08 to 0.99) |
Leukaemia (C91-C95) | ||||
Cases | 58 | 49 | 45 | 32 |
ERR (95% CI) | −0.54 (−3.54 to 2.45) | −0.55 (−1.49 to 0.39) | 2.13 (−11.9 to 16.2) | −0.50 (−3.98 to 2.98) |
*Adjusted for attained age (<25, 5-year intervals from the age of 25–84, ≥85 years), sex, birth year (<1960, 1960–1969, 1970–1979, ≥1980) and years of employment duration (<1, 1–5, 5–10, ≥10).
CNS, central nervous system; ERR, excess relative risk; ICD-10, International Classification of Diseases and Related Health Problems, 10th Revision; NHL, non-Hodgkin’s lymphoma.